在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Calcium-dependent phospholipase A2(PLA2G5) ELISA kit

  • 中文名稱:
    人鈣依賴性磷脂酶A2(PLA2G5)酶聯(lián)免疫試劑盒
  • 貨號:
    CSB-EL018103HU
  • 規(guī)格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    人鈣依賴性磷脂酶A2(PLA2G5)酶聯(lián)免疫試劑盒(CSB-EL018103HU)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的PLA2G5含量。PLA2G5是一種重要靶點。它屬于磷脂酶A2家族成員,在機體炎癥反應(yīng)、細胞膜代謝等過程中發(fā)揮作用。研究機制方面,主要聚焦其活性調(diào)節(jié)、與其他信號通路的相互作用,解析其在疾病發(fā)生發(fā)展中的角色以探索潛在治療策略。試劑盒檢測范圍為0.18 ng/mL-12 ng/mL,本產(chǎn)品適用于基礎(chǔ)科研領(lǐng)域,如探究PLA2G5在動脈粥樣硬化、肥胖相關(guān)脂代謝異?;蜓装Y性疾病模型中的表達變化,亦可用于評估藥物干預(yù)對磷脂酶活性調(diào)控的體外研究,為脂質(zhì)信號通路機制解析提供高效檢測工具。本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見產(chǎn)品說明書。
  • 別名:
    Ca2+ dependent phospholipase A2 ELISA Kit; Calcium dependent phospholipase A2 ELISA Kit; Calcium-dependent phospholipase A2 ELISA Kit; DKFZp686C2294 ELISA Kit; FRFB ELISA Kit; Group V phospholipase A2 ELISA Kit; GV PLA2 ELISA Kit; gVPLA2 ELISA Kit; hVPLA(2) ELISA Kit; MGC46205 ELISA Kit; OTTHUMP00000044655 ELISA Kit; PA2G5_HUMAN ELISA Kit; Phosphatidylcholine 2 acylhydrolase ELISA Kit; Phosphatidylcholine 2-acylhydrolase 5 ELISA Kit; Phospholipase A2 group V ELISA Kit; PLA2 10 ELISA Kit; PLA2 G5 ELISA Kit; PLA2-10 ELISA Kit; Pla2g5 ELISA Kit; sPLA2 Type V ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    0.18 ng/mL-12 ng/mL
  • 靈敏度:
    0.04 ng/mL
  • 反應(yīng)時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領(lǐng)域:
    Metabolism
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human PLA2G5 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    SampleSerum(n=4)
    1:5Average %89
    Range %84-93
    1:10Average %98
    Range %84-102
    1:20Average %104
    Range %100-110
    1:40Average %95
    Range %90-100
  • 回收率:
    The recovery of human PLA2G5 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 8480-88
    EDTA plasma (n=4)9691-100
  • 標(biāo)準(zhǔn)曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/mlOD1OD2AverageCorrected
    122.207 2.150 2.179 2.023
    61.768 1.801 1.785 1.629
    31.202 1.184 1.193 1.037
    1.50.683 0.634 0.659 0.503
    0.750.403 0.428 0.416 0.260
    0.3750.321 0.301 0.311 0.155
    0.180.245 0.227 0.236 0.080
    00.159 0.152 0.156
  • 數(shù)據(jù)處理:
  • 貨期:
    3-5 working days

產(chǎn)品評價

靶點詳情

  • 功能:
    Secretory calcium-dependent phospholipase A2 that primarily targets extracellular phospholipids. Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity), preferentially releasing fatty acyl groups with a low degree of unsaturation such as oleoyl (C18:1) and linoleoyl (C18:2) groups. Hydrolyzes low-density lipoprotein (LDL) phospholipids releasing unsaturated fatty acids that drive macrophage polarization toward an M2 phenotype. May act in an autocrine and paracrine manner. Contributes to lipid remodeling of cellular membranes at different subcellular locations and generation of lipid mediators involved in pathogen clearance. Cleaves sn-2 fatty acyl chains of cardiolipin, a major component of the inner membrane of mitochondria and bacterial membranes. Promotes phagocytosis of bacteria in macrophages through production of lysophosphatidylethanolamines. Displays bactericidal activity against Gram-positive bacteria by directly hydrolyzing phospholipids of the bacterial membrane. Promotes phagocytosis and killing of ingested fungi likely through controlling phagosome-lysosome fusion and phagosome maturation. Plays a role in biosynthesis of cysteinyl leukotrienes (CysLTs) in myeloid cells. In eosinophils, triggers perinuclear arachidonate release and LTC4 synthesis in a PLA2G4A-independent way. In neutrophils, amplifies CysLTs biosynthesis initiated by PLA2G4A. Promotes immune complex clearance in macrophages via stimulating synthesis of CysLTs, which act through CYSLTR1 to trigger phagocytosis. May regulate antigen processing in antigen-presenting cells. In pulmonary macrophages regulates IL33 production required for activation of group 2 innate lymphoid cells. May play a role in the biosynthesis of N-acyl ethanolamines that regulate energy metabolism. Hydrolyzes N-acyl phosphatidylethanolamines to N-acyl lysophosphatidylethanolamines, which are further cleaved by a lysophospholipase D to release N-acyl ethanolamines.
  • 基因功能參考文獻:
    1. Low GV-PLA2 expression is associated with cancer. PMID: 26715269
    2. The clinical findings in this family suggest a diagnosis of benign familial fleck retina with excellent prognosis, in which the PLA2G5 gene may play a role. PMID: 25549071
    3. sPLA2-V plays a thrombogenic role by impairing the ability of EPCR to promote protein C activation. PMID: 25069533
    4. results demonstrate that EPCR is overexpressed and mediates the aggressive behavior of rheumatoid synovial fibroblasts, and is likely driven by group V secretory phospholipase A2 PMID: 24495480
    5. expression of PLA2s-IIE and -V correlates with the development of calcification as well as the expression of pro-osteogenic molecules in human aortic valves PMID: 25132377
    6. There is no association between rs525380 polymorphism of PLA2G5 and coronary heart disease. PMID: 24563418
    7. Our results demonstrate the association of the PLA2G5 rs11573191 polymorphism with premature CAD. In our study, it was possible to distinguish one haplotype associated with increased risk of premature CAD and hypertension. PMID: 24959594
    8. Human group V secretory phospholipase A2 is associated with lipid rafts and internalized in a flotillindependent pathway. PMID: 24042857
    9. Our studies identified a unique function of gV-sPLA2 in activation of macrophages PMID: 23650617
    10. The effects of acidic pH on the activity of recombinant human group V secreted phospholipase A(2) (sPLA(2)-V) toward small VLDL (sVLDL), IDL, and LDL, on the binding of these apoB-100-containing lipoproteins to human aortic proteoglycans, were examined. PMID: 22041135
    11. Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retina PMID: 22137173
    12. Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro PMID: 20448053
    13. circulating human neutrophils express groups V and X sPLA(2) (GV and GX sPLA(2)) mRNA and contain GV and GX sPLA(2) proteins, whereas GIB, GIIA, GIID, GIIE, GIIF, GIII, and GXII sPLA(2)s are undetectable PMID: 11741884
    14. group V phospholipase A2 induces group IVA phospholipase A2-independent cysteinyl leukotriene synthesis in human eosinophils PMID: 12796497
    15. sPLA2-V expression in hepatocytes is induced by viral infection, fibrosis, and circulatory disturbance. Immunostaining using sPLA2-V antibody is useful for the detection of injured hepatocytes in patients with liver diseases. PMID: 15377291
    16. foam cell formation is promoted by a SR-A- and CD36-independent process that involves cellular proteoglycans and Group V secretory phospholipase A2-modified low density lipoprotein PMID: 16040605
    17. Group V sPLA2 was expressed in ischaemic cardiomyocytes around the lesion, while no expression was observed in normal heart. PMID: 16115226
    18. present results raise the possibility that group V and X sPLA2s may play a role in innate immunity against adenoviral infection in the respiratory tract PMID: 16146426
    19. group V PLA2 released from neighboring cells may function in triggering the activation of inflammatory cells under physiological conditions PMID: 16476735
    20. Group V phospholipase A2, endogenously secreted from activated epithelial cells, promotes secretion of leukotriene C4 from cocultured eosinophils. PMID: 16785555
    21. PLA2G5 tSNP haplotypes demonstrate an association with total and LDL cholesterol and oxLDL/LDL. PMID: 17545304

    顯示更多

    收起更多

  • 相關(guān)疾病:
    Fleck retina, familial benign (FRFB)
  • 亞細胞定位:
    Secreted. Cell membrane. Cytoplasmic vesicle, phagosome. Recycling endosome. Golgi apparatus, cis-Golgi network. Golgi apparatus, trans-Golgi network.
  • 蛋白家族:
    Phospholipase A2 family
  • 組織特異性:
    Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). Expressed in monocytes and macrophages.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 9038

    OMIM: 228980

    KEGG: hsa:5322

    STRING: 9606.ENSP00000364249

    UniGene: Hs.319438



主站蜘蛛池模板: 女乱高潮久久久久久爽爽| 天天狠天天透天天伊人| 一二三四在线视频观看社区| 99在线精品免费视频| 国产精品无码综合区| 成年女人午夜性视频| 柠檬福利第一导航在线| 福利一区二区三区视频在线观看| 99国产欧美久久久精品蜜芽| 一本久久a久久免费精品不卡| 日本护士xxxxhd少妇| 久久国产av影片| 无码人妻一区二区三区线| 国产精品无码一区二区桃花视频| 国产美女爽到喷出水来视频| 国产成人av在线一区二区三区 | 蜜臀精品无码av在线播放| 国产午夜福利片| 欧美人成视频在线视频| 一本大道大臿蕉视频无码| 国产午夜成人久久无码一区二区| 精品久久久久国产免费| 清纯唯美经典一区二区| 人妻在线无码一区二区三区| 欧美日韩色另类综合| 精品久久久久久无码人妻蜜桃 | 精品国产一区二区av麻豆不卡| 日日摸日日碰夜夜爽亚洲综合| 国产乱妇无码大片在线观看| 久久综合88熟人妻| 人人妻人人澡人人爽人人精品97| 国产成人午夜福利免费无码r| 日本欧美一区二区三区乱码| 欧美 丝袜 自拍 制服 另类| 奇米在线7777在线精品| 亚洲久久久久久中文字幕| 精品久久久久久无码人妻热| 国产女人高潮嗷嗷嗷叫| 人妻.中文字幕无码| 成在线人视频免费视频| 日本三级成本人网站|